Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Identifying safe long term investments is essential for risk-averse investors. Learn about reliable options to secure your financial future.
26,844 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A newly launched XRP ETF promises to deliver twice the daily moves of XRP, inviting traders to pursue a quick double ...
A hantavirus outbreak can spark biotech chatter, but three solid realities—limited demand, tough development paths, a...
SpaceX is poised to launch one of the largest IPOs in history. As the market watches, the bigger question is whether ...
The first half of the year brought a sharp move for ServiceNow as AI expectations collided with reality. This article...
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Ethereum slid about 5% to $2,100 amid a broader market pullback, but on-chain metrics point to a possible long-term b...
A major fund just raised its stake in a leading data-center company. This article breaks down what that move could me...
A regulatory milestone sparked a notable move for Oklo shares, highlighting how news on licensing can lift niche ener...
A rising chorus of lawmakers is calling for formal investigations into crypto profits tied to a high-profile figure. ...
Dive into a practical guide on Revolution Medicines earnings. Learn to parse transcripts, spot the signals that matte...
United Airlines will cut about 5% of capacity this quarter as jet fuel prices climb amid geopolitical tensions. The m...